Literature DB >> 20719078

Antiproinflammatory effects of iodixanol (OptiPrep)-based density gradient purification on human islet preparations.

A Mita1, C Ricordi, S Messinger, A Miki, R Misawa, S Barker, R D Molano, R Haertter, A Khan, S Miyagawa, A Pileggi, L Inverardi, R Alejandro, B J Hering, H Ichii.   

Abstract

Islet isolation and purification using a continuous density gradient may reduce the volume of tissue necessary for implantation into patients, therefore minimizing the risks associated with intraportal infusion in islet transplantation. On the other hand, the purification procedure might result in a decreased number of islets recovered due to various stresses such as exposure to cytokine/chemokine. While a Ficoll-based density gradient has been widely used in purification for clinical trials, purification with iodixanol (OptiPrep) has been recently reported in islet transplant series with successful clinical outcomes. The aim of the current study was to compare the effects of the purification method using OptiPrep-based and Ficoll-based density gradients. Human islet isolations were performed using a modified automated method. After the digestion phase, pre-purification digests were divided into two groups and purified using a semiautomated cell processor with either a continuous Ficoll- or OptiPrep-based density gradient. The quantity, purity, viability, and cellular composition of islet preparations from each group were assessed. Cytokine/chemokine and tissue factor production from islet preparations after 48-h culture were also measured. Although islet purity, post-purification IEQ, islet recovery rate, FDA/PI, and fractional β-cell viability were comparable, β-cell mass after 48-h culture significantly improved in the OptiPrep group when compared to the Ficoll group. The production of cytokine/chemokine including IL-1β, TNF-α, IFN-γ, IL-6, IL-8, MIP-1β, MCP-1, and RANTES but not tissue factor from the OptiPrep group was significantly lower during 48-h culture after isolation. Each preparation contained the similar number of ductal cells and macrophages. Endotoxin level in both gradient medium was also comparable. The purification method using OptiPrep gradient media significantly reduced cytokine/chemokine production but not tissue factor from human islet preparations and improved β-cell survival during pretransplant culture. Our results suggest that the purification method using OptiPrep gradient media may be of assistance in increasing successful islet transplantation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20719078      PMCID: PMC3777530          DOI: 10.3727/096368910X516600

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  47 in total

1.  A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations.

Authors:  Hirohito Ichii; Luca Inverardi; Antonello Pileggi; R Damaris Molano; Over Cabrera; Alejandro Caicedo; Shari Messinger; Yoshikazu Kuroda; Per-Olof Berggren; Camillo Ricordi
Journal:  Am J Transplant       Date:  2005-07       Impact factor: 8.086

2.  Improved human islet isolation using nicotinamide.

Authors:  H Ichii; X Wang; S Messinger; A Alvarez; C Fraker; A Khan; Y Kuroda; L Inverardi; J A Goss; R Alejandro; C Ricordi
Journal:  Am J Transplant       Date:  2006-07-06       Impact factor: 8.086

3.  Endotoxin-mediated activation of cytokine production in human PBMCs by collagenase and Ficoll.

Authors:  H Jahr; G Pfeiffer; B J Hering; K Federlin; R G Bretzel
Journal:  J Mol Med (Berl)       Date:  1999-01       Impact factor: 4.599

4.  Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience.

Authors:  Tatiana Froud; Camillo Ricordi; David A Baidal; Muhammad M Hafiz; Gaston Ponte; Pablo Cure; Antonello Pileggi; Raffaella Poggioli; Hirohito Ichii; Aisha Khan; Jacqueline V Ferreira; Alberto Pugliese; Violet V Esquenazi; Norma S Kenyon; Rodolfo Alejandro
Journal:  Am J Transplant       Date:  2005-08       Impact factor: 8.086

5.  Islet isolation for allotransplantation: variables associated with successful islet yield and graft function.

Authors:  R Nano; B Clissi; R Melzi; G Calori; P Maffi; B Antonioli; S Marzorati; L Aldrighetti; M Freschi; T Grochowiecki; C Socci; A Secchi; V Di Carlo; E Bonifacio; F Bertuzzi
Journal:  Diabetologia       Date:  2005-04-14       Impact factor: 10.122

6.  Successful islet transplantation from nonheartbeating donor pancreata using modified Ricordi islet isolation method.

Authors:  Shinichi Matsumoto; Teru Okitsu; Yasuhiro Iwanaga; Hirofumi Noguchi; Hideo Nagata; Yukihide Yonekawa; Yuichiro Yamada; Kazuhito Fukuda; Toshiya Shibata; Yasunari Kasai; Taira Maekawa; Hiromi Wada; Takayuki Nakamura; Koichi Tanaka
Journal:  Transplantation       Date:  2006-08-27       Impact factor: 4.939

7.  Tumor necrosis factor-alpha production by human islets leads to postisolation cell death.

Authors:  Stephen Hanley; Shuqing Liu; Mark Lipsett; Mauro Castellarin; Lawrence Rosenberg; Jean Tchervenkov; Steven Paraskevas
Journal:  Transplantation       Date:  2006-09-27       Impact factor: 4.939

8.  Five-year follow-up after clinical islet transplantation.

Authors:  Edmond A Ryan; Breay W Paty; Peter A Senior; David Bigam; Eman Alfadhli; Norman M Kneteman; Jonathan R T Lakey; A M James Shapiro
Journal:  Diabetes       Date:  2005-07       Impact factor: 9.461

9.  Shipment of human islets for transplantation.

Authors:  H Ichii; Y Sakuma; A Pileggi; C Fraker; A Alvarez; J Montelongo; J Szust; A Khan; L Inverardi; B Naziruddin; M F Levy; G B Klintmalm; J A Goss; R Alejandro; C Ricordi
Journal:  Am J Transplant       Date:  2007-04       Impact factor: 8.086

10.  Refinement of the automated method for human islet isolation and presentation of a closed system for in vitro islet culture.

Authors:  Masafumi Goto; Torsten M Eich; Marie Felldin; Aksel Foss; Ragnar Källen; Kaija Salmela; Annika Tibell; Gunnar Tufveson; Keisei Fujimori; Margareta Engkvist; Olle Korsgren
Journal:  Transplantation       Date:  2004-11-15       Impact factor: 4.939

View more
  12 in total

Review 1.  Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome.

Authors:  A M James Shapiro
Journal:  Rev Diabet Stud       Date:  2012-12-28

2.  Filtration is a time-efficient option to Histopaque, providing good-quality islets in mouse islet isolation.

Authors:  Miriam Ramírez-Domínguez; Luis Castaño
Journal:  Cytotechnology       Date:  2014-01-19       Impact factor: 2.058

Review 3.  Pancreatic islet transplantation: toward definitive treatment for diabetes mellitus.

Authors:  Tadashi Takaki; Masayuki Shimoda
Journal:  Glob Health Med       Date:  2020-08-31

Review 4.  Update on islet transplantation.

Authors:  Michael McCall; A M James Shapiro
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

5.  Clinical allogeneic and autologous islet cell transplantation: update.

Authors:  Shinichi Matsumoto
Journal:  Diabetes Metab J       Date:  2011-06-30       Impact factor: 5.376

6.  Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation.

Authors:  Preeti Chhabra; Kenneth L Brayman
Journal:  J Transplant       Date:  2011-10-20

7.  Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation.

Authors:  Cyrus Jahansouz; Cameron Jahansouz; Sean C Kumer; Kenneth L Brayman
Journal:  J Transplant       Date:  2011-10-15

8.  Analysis of beta-cell gene expression reveals inflammatory signaling and evidence of dedifferentiation following human islet isolation and culture.

Authors:  Sarita Negi; Arif Jetha; Reid Aikin; Craig Hasilo; Rob Sladek; Steven Paraskevas
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

9.  Isolation of senescent cells by iodixanol (OptiPrep) density gradient-based separation.

Authors:  Kristina Kovacovicova; Manlio Vinciguerra
Journal:  Cell Prolif       Date:  2019-09-13       Impact factor: 6.831

10.  Tacrolimus inhibits the revascularization of isolated pancreatic islets.

Authors:  Ryuichi Nishimura; Sho Nishioka; Ikuma Fujisawa; Hitoshi Shiku; Miki Shimada; Satoshi Sekiguchi; Keisei Fujimori; Akira Ushiyama; Tomokazu Matsue; Noriaki Ohuchi; Susumu Satomi; Masafumi Goto
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.